Rema Raman

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population
    Rema Raman
    Department of Neurosciences, University of California San Diego, La Jolla, 92093 0717, USA
    Alzheimer Dis Assoc Disord 23:333-6. 2009
  2. ncbi Late night activity regarding stroke codes: LuNAR strokes
    Gilda Tafreshi
    Department of Neurosciences, University of California, San Diego, CA 92103, USA
    Int J Stroke 7:473-6. 2012
  3. ncbi Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment
    Danielle C Whitehair
    Department of Neurosciences, University of California, San Diego, CA, USA
    Alzheimers Dement 6:412-9. 2010
  4. ncbi Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke
    Branko N Huisa
    Department of Neurosciences, University of California San Diego, San Diego, California 92103 8466, USA
    J Stroke Cerebrovasc Dis 19:475-9. 2010
  5. ncbi Gender differences in acute stroke treatment: the University of California San Diego experience
    Gilda M Tafreshi
    University of California San Diego, San Diego, Calif, USA
    Stroke 41:1755-7. 2010
  6. ncbi Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans
    Paul S Aisen
    Department of Neurosciences, University of California San Diego, CA, USA
    Alzheimers Dement 6:239-46. 2010
  7. ncbi Assessment of long-term outcomes for the STRokE DOC telemedicine trial
    Brett C Meyer
    Department of Neurosciences, University of California San Diego School of Medicine, San Diego, CA 92103 8466, USA
    J Stroke Cerebrovasc Dis 21:259-64. 2012
  8. ncbi Can comprehensive stroke centers erase the 'weekend effect'?
    Karen C Albright
    Department of Neurosciences, University of California San Diego, CA, USA
    Cerebrovasc Dis 27:107-13. 2009
  9. ncbi Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease
    Adam S Fleisher
    University of California, San Diego, La Jolla, CA 92037, USA
    Arch Neurol 65:1031-8. 2008
  10. ncbi Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies
    Joanne M Hamilton
    Department of Neurosciences, University of California, USA
    Neuropsychology 22:729-37. 2008

Collaborators

Detail Information

Publications11

  1. ncbi MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population
    Rema Raman
    Department of Neurosciences, University of California San Diego, La Jolla, 92093 0717, USA
    Alzheimer Dis Assoc Disord 23:333-6. 2009
    ..To determine if a self-selected group of participants who enroll in an imaging substudy of Alzheimer disease (AD) clinical trials is representative of the overall study sample...
  2. ncbi Late night activity regarding stroke codes: LuNAR strokes
    Gilda Tafreshi
    Department of Neurosciences, University of California, San Diego, CA 92103, USA
    Int J Stroke 7:473-6. 2012
    ..There is diurnal variation for cardiac arrest and sudden cardiac death. Stroke may show a similar pattern. We assessed whether strokes presenting during a particular time of day or night are more likely of vascular etiology...
  3. ncbi Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment
    Danielle C Whitehair
    Department of Neurosciences, University of California, San Diego, CA, USA
    Alzheimers Dement 6:412-9. 2010
    ..We examine the prospective association of APOE varepsilon4 allele status on measures of cognitive and functional decline in subjects with amnestic MCI (aMCI)...
  4. ncbi Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke
    Branko N Huisa
    Department of Neurosciences, University of California San Diego, San Diego, California 92103 8466, USA
    J Stroke Cerebrovasc Dis 19:475-9. 2010
    ..079). Initial ASPECTS was similar in patients with wake-up stroke and those with 4 hours of symptoms. This suggests that a subset of wake-up stroke patients might be suitable for thrombolytic therapy...
  5. ncbi Gender differences in acute stroke treatment: the University of California San Diego experience
    Gilda M Tafreshi
    University of California San Diego, San Diego, Calif, USA
    Stroke 41:1755-7. 2010
    ..Data regarding gender differences in acute stroke treatment shows a delayed treatment and evaluation in women with stroke, associated with poorer outcome...
  6. ncbi Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans
    Paul S Aisen
    Department of Neurosciences, University of California San Diego, CA, USA
    Alzheimers Dement 6:239-46. 2010
    ..The resulting data would provide valuable data on the earliest stages of AD, and support the development of interventions in these critically important populations...
  7. ncbi Assessment of long-term outcomes for the STRokE DOC telemedicine trial
    Brett C Meyer
    Department of Neurosciences, University of California San Diego School of Medicine, San Diego, CA 92103 8466, USA
    J Stroke Cerebrovasc Dis 21:259-64. 2012
    ..This design is limited by the time since original enrollment and resultant inability to contact participants. Although these findings can add to the limited data on telemedicine outcomes, a prospective trial is needed...
  8. ncbi Can comprehensive stroke centers erase the 'weekend effect'?
    Karen C Albright
    Department of Neurosciences, University of California San Diego, CA, USA
    Cerebrovasc Dis 27:107-13. 2009
    ..Our aim was to assess stroke patient outcomes in order to determine the significance of the 'weekend effect' at 2 comprehensive stroke centers...
  9. ncbi Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease
    Adam S Fleisher
    University of California, San Diego, La Jolla, CA 92037, USA
    Arch Neurol 65:1031-8. 2008
    ..To evaluate the safety, tolerability, and amyloid beta (Abeta) response to the gamma-secretase inhibitor LY450139 in Alzheimer disease...
  10. ncbi Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies
    Joanne M Hamilton
    Department of Neurosciences, University of California, USA
    Neuropsychology 22:729-37. 2008
    ....
  11. ncbi Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study
    Brett C Meyer
    Department of Neurosciences, El Centro Regional Medical Center, El Centro, CA, USA
    Lancet Neurol 7:787-95. 2008
    ....